DOI: 10.2174/2210296511202010037
关键词:
摘要: The establishment of the first culture a human embryonic stem cell (hESC) line as immortal and capable producing virtually every body generated high expectations regarding their potential use in regenerative medicine research applications. achievement generating pluripotent cells from adult tissues further raised those expectations, by ideally eliminating ethical safety concerns cells. Patient-specific could be generated, no embryo would have been used. After six years induced lines somatic tissues, advancements made but much still needs to conducted order produce clinically relevant differentiated present review outlines most recent inventions basic related clinical applications Its main objective is contribute concise compilation advances derivation, culture, directed differentiation development application processes cells, treat disease. Registered patents bibliography reported mostly past two considered for inclusion, although literature has included where needed explain